kontrast-01: jdq443 and tno155 in the treatment of nsclc
Published 11 months ago • 66 plays • Length 3:44Download video MP4
Download video MP3
Similar videos
-
4:16
tno155 in advanced solid tumors
-
2:15
the impact of durvalumab for resectable non-small cell lung cancer
-
1:19
ly3537982: a novel kras g12c inhibitor in solid tumors
-
0:51
bi 907828: targeting mdm2 in solid tumors
-
0:50
kras g12c emerges as new potential target in non-small cell lung cancer
-
1:58
results from phase i/ii study of ds-7300a in advanced solid tumors
-
6:55
treatment strategies for kras nsclc - 2022 program: targeted therapies forum
-
10:45
what the new kras inhibitor means for lung cancer - medpage today
-
2:44
biomarkers of treatment response in patients with mmr-proficient crc
-
1:51
optimal chemotherapy combinations in tnbc gbrca subtypes
-
0:16
activated t cell attacks a cancer cell
-
6:52
kras mutations in solid tumors
-
2:40
immunotherapy in common solid tumors: an overview
-
1:14
pencil beam scanning proton therapy
-
4:25
sb2115 plus nivo for solid tumors
-
1:55
diagnosing melanoma in the digital era
-
2:44
neoxpress, a novel tcr platform to target solid tumors
-
2:49
what is multi-focal lung cancer?